Advertisement

Oral semaglutide cost effective for T2DM in UK

    • 2 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Notes

    1. 1.

      2018 British pounds

    Reference

    1. Bain SC, et al. Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme. Diabetes Therapy : Jan 2019. Available from: URL: http://doi.org/10.1007/s13300-019-00736-6

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Oral semaglutide cost effective for T2DM in UK. PharmacoEcon Outcomes News 844, 27 (2020) doi:10.1007/s40274-020-6490-5

    Download citation